Experience

Philippe is a Principal, responsible for the group benefits practice in Eckler’s Montreal office. He has 20+ years of consulting experience in group benefits, pension plans and mergers and acquisitions (M&A).

His expertise in group benefits and pension consulting centers on strategic issues, plan design at the national level, communication to plan sponsors and participants. He also provides clients with technical actuarial analysis for cost projections, group benefits negotiation at renewal/market search, pension actuarial funding valuation and accounting disclosures.

Before joining Eckler, Philippe worked in New York for a global consulting firm in their M&A department. In this role, he led the due diligence technical work regarding employee benefits in deals involving Canadian companies.

Philippe is passionate about his profession and his commitment to his clients. He is known for his strong technical expertise and his ability to make the complex simple for plan members and clients.

In 2019, Philippe was selected by Avantages magazine as one of 30 exceptional personalities in the Quebec employee benefits industry. Heavily involved in the industry, Philippe is frequently asked to participate in events across Canada, whether as a presenter or speaker.

Areas of Expertise

  • Annuity purchase
  • Benefit plan design and harmonization
  • Change management
  • Employee life and health trusts
  • Employee training sessions
  • Mergers and acquisitions
  • Project management
  • Supplemental executive retirement programs (SERPs)
  • Total rewards

Professional Qualifications

Professional Qualifications
  • Fellow of the Canadian Institute of Actuaries (FCIA)
  • Fellow of the Society of Actuaries (FSA)
Professional Activities
  • Founding member of l’Association de la Retraite et des Avantages Sociaux du Québec (ARASQ)

Thought Leadership

As a member of the Editorial Board, Philippe helps provide direction for Eckler’s monthly GroupNews publication that provides commentary on the issues affecting Canadian group benefit plans. The most recent issues can be accessed below.

Philippe also contributes his insights to a variety of publications and conferences. Here’s just a sampling:

How plan sponsors, insurers should approach Wegovy rollout in Canada
Benefits Canada – June 2024

Quebec biosimilars policy could cut drug costs for plan sponsors: expert
Benefits Canada – April 2022

How Rolls Royce Canada is reducing drug plan costs while maintaining benefits offering
Benefits Canada – October 2021

What’s the solution to increasing drug-plan costs for plan sponsors?
Benefits Canada – April 2021

Assurance médicaments : les coûts de mutualisation toujours en hausse
Avantages – Janvier 2021

Quebec drug pooling corp.’s cost increases mean premium hikes for plan sponsors
Benefits Canada – January 2020

30 personnalités exceptionnelles du secteur des avantages sociaux au Québec
Avantages – September 2019

Assurance médicaments : cesser de tout mutualiser
Avantages – October 2018

Eckler News and Insights

GroupNews - October 2022

In this issue of GroupNews you’ll find updates on prescription co-pay and premium amendments under the New Brunswick Drug Plan; better access to diagnostic imaging ...
Learn More

GroupNews - September 2022

This issue of GroupNews reports on new measures in Alberta and Manitoba to reduce surgical wait times, proposed federal amendments to medical expense tax credits ...
Learn More

GroupNews - July 2022

This issue of GroupNews provides an update on the new public drug plan rates in Quebec, expanded coverage for cystic fibrosis in Ontario and Alberta, ...
Learn More

GroupNews - October 2021

This month’s GroupNews provides updates on provincial uptake of new cystic fibrosis medication, new medicare coverage for pharmacy costs in New Brunswick, improved access to ...
Learn More

GroupNews - September 2021

In this month’s GroupNews we look at a new study from the Canadian Institute for Health Information (CIHI) on how the COVID-19 pandemic has affected ...
Learn More

GroupNews - July 2021

This month’s GroupNews includes various updates from the federal government on drug pricing regulations and Bills C-30 and C-35, along with updates from Quebec and ...
Learn More

GroupNews - June 2021

In the June issue of GroupNews, we look at expanded coverage for treating diabetes in Saskatchewan and British Columbia, an appeal court ruling in Quebec ...
Learn More

GroupNews - February 2021

In this month’s issue of GroupNews, we look at provincial coverage changes in Ontario and Alberta, new pharmacy services introduced in Quebec, potential new limits ...
Learn More

Understanding the Quebec Drug Insurance Pooling Corporation terms and conditions

Understanding the Québec Drug Insurance Pooling Corporation (QDIPC) terms and conditions High-cost drugs have always posed a significant risk for the financial health of group ...
Learn More

GroupNews - January 2021

This month’s GroupNews examines new regulations for pharmacists in Quebec, a new research report on the drivers of cost growth for private drug plan claims, ...
Learn More

GroupNews - December 2020

The December issue of Group News summarizes the 2021 Canada Pension Plan and Quebec Pension Plan contribution rates and highlights the Government of Canada’s draft ...
Learn More

GroupNews - November 2020

This month’s GroupNews highlights a recent Conference Board of Canada report that predicts health care costs will increase due to COVID-19, recent developments impacting plans ...
Learn More

Through the looking glass: The rise of virtual healthcare and its impact on benefit plan sponsors in a post-COVID world

There is no doubt that COVID-19 has brought significant disruption to our personal and professional lives. While lockdown restrictions are easing, the impact of the ...
Learn More

GroupNews - October 2020

In our October issue of GroupNews, we look at proposed changes in Quebec to make parental insurance benefits more flexible, changes in Manitoba to expand ...
Learn More

GroupNews -
September 2020

Our September issue of GroupNews provides information on the Employment Insurance premium rate for 2021, new biosimilars approved for launch in Canada and summarizes a ...
Learn More

GroupNews - August 2020

This month’s issue of GroupNews covers new legislation in BC to help employers cope with COVID-19 fallout along with expanded financial support and expanded drug ...
Learn More

Accounting for municipal sector pension plans: Tax relief measure to limit the effects of COVID-19

In response to the potential impact of COVID-19 on the financial health of defined benefit pension plans and consequently on the tax burden related to ...
Learn More

GroupNews - June 2020

Our June issue of GroupNews provides important COVID-19 related updates on Health Care Spending Accounts, emergency leave in Ontario, Alberta’s Biosimilar Initiative and Quebec’s Health ...
Learn More

GroupNews - May 2020

Eckler’s GroupNews monthly newsletter provides commentary on the issues affecting Canadian group benefit plans. In this edition: Ontario issues regulations amending Ontario Drug Benefit Act ...
Learn More

GroupNews Extra - May 2020

This GroupNews Extra looks at the impact of COVID-19 has had on the claims experience of extended health and dental plans and what’s coming next.
Learn More

GroupNews - April 2020

In this month’s issue of GroupNews, we provide details on Manitoba’s pharmacare deductible, changes to parental leave in Saskatchewan, and amendments to the Ontario Drug ...
Learn More

GroupNews - March 2020

Eckler’s GroupNews monthly newsletter provides commentary on the issues affecting Canadian group benefit plans. In this edition: Report on 2020 health and dental trend factors ...
Learn More

GroupNews - February 2020

This issue of GroupNews, provides updates on Alberta’s move to partner with private clinics to provide surgeries, a decision from the BC Human Rights Commission ...
Learn More

GroupNews - January 2020

In this edition of GroupNews, we provide updates on changes for pharmacists and massage therapists in Nova Scotia, Alberta’s Bill 21 and its new biosimilar ...
Learn More